News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Abbott Laboratories to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal
September 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, Sept 21 (Reuters) - Abbott Laboratories Inc (ABT.N) plans to cut 3,000 jobs, or about 3 percent of its workforce, following its purchase of Solvay's (SOLB.BR) pharmaceuticals business.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
MORE ON THIS TOPIC
Job Trends
Keeping the Door Open: Many Would Return to Companies That Laid Them Off
March 5, 2026
·
5 min read
·
Angela Gabriel
Career Advice
The Top 12 Companies Hiring in Biopharma Now
March 5, 2026
·
1 min read
·
Angela Gabriel
Job Trends
The Job Market May Be Warming—What Does That Mean for You?
March 4, 2026
·
4 min read
·
Angela Justice
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
·
1 min read
·
Angela Gabriel
